Devalina Law, Ph.D. (she/her/hers)

AbbVie Inc.

Poster(s):

• (M1230-12-79) Characterization and Performance of 60% Drug Loaded Freeze-Dried Amorphous Nanoparticle Tablet of a BCS IV Compound: ABT-530
  Monday, October 23, 2023

  12:30 PM – 1:30 PM ET

• (T1430-01-02) Design and Development of High Drug Loading Commercial Formulation for a Salt Drug Substance with High Propensity of Solid Form Conversion
  Tuesday, October 24, 2023

  2:30 PM – 3:30 PM ET

• (T1430-12-83) Design of a Re-Dispersible High Drug Load Amorphous ABT-530 Formulation: Impact of Formulation Composition on Processing and Performance
  Tuesday, October 24, 2023

  2:30 PM – 3:30 PM ET

• (M1030-12-82) Investigation of Rational Selection of Small Molecule Acids in pH-Independent Extended-Release Matrix Tablets of Weakly Basic Drugs
  Monday, October 23, 2023

  10:30 AM – 11:30 AM ET